Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 8 |
GO:0110165 | cellular anatomical entity | 1 | 8 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: A0A3S5H7U3
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_PCSK_KEX2_1 | 54 | 56 | PF00082 | 0.666 |
CLV_PCSK_PC1ET2_1 | 54 | 56 | PF00082 | 0.698 |
CLV_PCSK_SKI1_1 | 18 | 22 | PF00082 | 0.652 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.661 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.454 |
DOC_CYCLIN_RxL_1 | 2 | 10 | PF00134 | 0.502 |
DOC_USP7_MATH_1 | 3 | 7 | PF00917 | 0.501 |
DOC_USP7_MATH_1 | 40 | 44 | PF00917 | 0.555 |
DOC_USP7_MATH_1 | 75 | 79 | PF00917 | 0.515 |
DOC_WW_Pin1_4 | 82 | 87 | PF00397 | 0.357 |
LIG_Clathr_ClatBox_1 | 137 | 141 | PF01394 | 0.357 |
LIG_FHA_1 | 90 | 96 | PF00498 | 0.333 |
LIG_FHA_2 | 112 | 118 | PF00498 | 0.583 |
LIG_LIR_Gen_1 | 141 | 147 | PF02991 | 0.374 |
LIG_LIR_Nem_3 | 141 | 147 | PF02991 | 0.374 |
LIG_LIR_Nem_3 | 81 | 87 | PF02991 | 0.321 |
LIG_PDZ_Class_2 | 142 | 147 | PF00595 | 0.566 |
LIG_SH2_CRK | 130 | 134 | PF00017 | 0.391 |
LIG_SH2_CRK | 84 | 88 | PF00017 | 0.369 |
LIG_SH2_CRK | 97 | 101 | PF00017 | 0.357 |
LIG_SH2_NCK_1 | 84 | 88 | PF00017 | 0.408 |
LIG_SH2_STAP1 | 109 | 113 | PF00017 | 0.568 |
LIG_SH2_STAT5 | 118 | 121 | PF00017 | 0.651 |
LIG_SH2_STAT5 | 57 | 60 | PF00017 | 0.482 |
LIG_SUMO_SIM_par_1 | 98 | 104 | PF11976 | 0.374 |
LIG_SxIP_EBH_1 | 55 | 69 | PF03271 | 0.490 |
LIG_TYR_ITIM | 82 | 87 | PF00017 | 0.357 |
LIG_TYR_ITIM | 95 | 100 | PF00017 | 0.357 |
MOD_CK1_1 | 36 | 42 | PF00069 | 0.544 |
MOD_CK1_1 | 78 | 84 | PF00069 | 0.425 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.700 |
MOD_GlcNHglycan | 46 | 49 | PF01048 | 0.728 |
MOD_GSK3_1 | 107 | 114 | PF00069 | 0.589 |
MOD_GSK3_1 | 29 | 36 | PF00069 | 0.490 |
MOD_GSK3_1 | 3 | 10 | PF00069 | 0.513 |
MOD_GSK3_1 | 40 | 47 | PF00069 | 0.464 |
MOD_GSK3_1 | 74 | 81 | PF00069 | 0.453 |
MOD_GSK3_1 | 82 | 89 | PF00069 | 0.378 |
MOD_N-GLC_1 | 107 | 112 | PF02516 | 0.442 |
MOD_NEK2_1 | 111 | 116 | PF00069 | 0.592 |
MOD_NEK2_1 | 29 | 34 | PF00069 | 0.565 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.503 |
MOD_NEK2_1 | 58 | 63 | PF00069 | 0.474 |
MOD_NEK2_1 | 7 | 12 | PF00069 | 0.487 |
MOD_PIKK_1 | 68 | 74 | PF00454 | 0.443 |
MOD_PIKK_1 | 7 | 13 | PF00454 | 0.517 |
MOD_PKA_2 | 29 | 35 | PF00069 | 0.565 |
MOD_Plk_1 | 107 | 113 | PF00069 | 0.614 |
MOD_Plk_4 | 123 | 129 | PF00069 | 0.518 |
MOD_Plk_4 | 58 | 64 | PF00069 | 0.473 |
MOD_Plk_4 | 78 | 84 | PF00069 | 0.278 |
MOD_Plk_4 | 89 | 95 | PF00069 | 0.391 |
MOD_ProDKin_1 | 82 | 88 | PF00069 | 0.357 |
TRG_ENDOCYTIC_2 | 130 | 133 | PF00928 | 0.350 |
TRG_ENDOCYTIC_2 | 84 | 87 | PF00928 | 0.369 |
TRG_ENDOCYTIC_2 | 97 | 100 | PF00928 | 0.357 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PAG2 | Leptomonas seymouri | 74% | 100% |
A0A0S4JA46 | Bodo saltans | 37% | 100% |
A0A422MW56 | Trypanosoma rangeli | 50% | 100% |
A4HLH1 | Leishmania braziliensis | 86% | 100% |
A4I8Y1 | Leishmania infantum | 100% | 100% |
E9B3V0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 91% | 100% |
Q4Q474 | Leishmania major | 96% | 100% |